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Abstract: Otto Warburg, a Nobel prize winner, observed that cancer cells typically “switch”
from aerobic to anaerobic respiration. He hypothesized that mitochondrial damage induces
neoplastic transformation. In contrast, pathological aging is observed mainly in neuron cells in
neurodegenerative diseases. Oxidative respiration is particularly active in neurons. There is inverse
comorbidity between cancer and neurodegenerative diseases. This led to the creation of the “inverse
Warburg hypothesis”, according to which excessive mitochondrial activity induces pathological aging.
The findings of our studies suggest that both the Warburg effect and the “inverse Warburg hypothesis”
can be elucidated by the activation or suppression of apoptosis through oxidative respiration. The key
outcome of our phylogenetic studies was the discovery that apoptosis and apoptosis-like cell death
evolved due to an evolutionary “arms race” conducted between “prey” protomitochondrion and
“predator” primitive eukaryotes. The ancestral protomitochondrial machinery produces and releases
toxic mitochondrial proteins. Extant apoptotic factors evolved from these toxins. Our experiments
indicate that the mitochondrial machinery is directly involved in adaptation to aerobic conditions.
Additionally, our hypothesis is supported by the fact that different apoptotic factors are directly
involved in respiration.
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1. Introduction
Aging is one of the biggest mysteries of human biology. The progress of organismal aging
leads inevitably to age-related diseases, such as cancer and neurodegenerative disease [1–3].
However, the mechanisms involved in cancer formation are almost the reverse of those involved
in neurodegenerative diseases.
The development of both diseases is caused by perturbations in apoptosis regulation, which
is a type of programmed cell death. Apoptosis can be distinguished from other kinds of cell death.
There are cytological hallmarks of apoptosis such as the release of mitochondrial apoptotic factors,
activation of apoptotic proteases, disintegration of the nucleus, and self-degradation of DNA [4].
Animal apoptosis is based on the centrality of caspases and a key pathway named the “canonical
apoptotic pathway”, which was firstly described in Caenorhabditis elegans [5–8]. These mechanisms are
evolutionarily conserved throughout the animal world, but they are not conserved in other eukaryotic
organisms [9–11].
Oncogenic mutations causing cancer lead to the suppression of apoptotic cell death and enhanced
cellular proliferation [12,13]. Apoptosis is one of the main animal intrinsic anticancer mechanisms.
In contrast, neurodegenerative diseases occur in terminally differentiated neuronal cells and lead to
their apoptotic death [14,15]. Also, the metabolism of cancer and neuron cells is very different.
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Otto Warburg, a Nobel prize winner, observed that cancer cells typically shift their metabolism
toward non-mitochondrial anaerobic respiration [16]. He hypothesized that mitochondrial damage
induces neoplastic transformation. Later, it turned out that, in cancer cells, a shift towards anaerobic
respiration is not always observed (i.e., there are cancers in which mitochondrial respiration is very
active). Assuming that the Warburg effect plays a role in neoplastic transformation, it may (i) stimulate
proliferation, and (ii) inhibit cell death in tumor cells. There are many different mechanisms by which
the Warburg effect stimulates cancer growth and suppresses apoptosis. Mathematical models suggest
that due to the Warburg effect, cancer cells transform glucose into biomass more rapidly (which
supports cellular proliferation).
In contrast to the cancer cells in which mitochondrial metabolism tends to be suppressed,
the mitochondrial metabolism of neuron cells is extremely active. In this tissue, pathological aging leads
to apoptotic cell death. It was hypothesized that an ‘inverse’ Warburg effect exists. According to this
hypothesis, oxidative respiration stimulates pathological cell death. Perhaps not surprisingly, different
studies have indicated that there is inverse comorbidity between cancer and neurodegenerative
diseases [17–21].
To sum up, cancer and neurodegenerative diseases are caused by perturbations in apoptosis.
There is unusual mitochondrial metabolism in affected tissues and according to the Warburg and
inverse Warburg effects, metabolism impacts the development of diseases.
Mitochondria are also key players in apoptosis.
Phylogenetic studies have revealed the origin of mitochondrial apoptosis and eukaryotic oxidative
respiration. Mitochondria are actually simplified endosymbiotic bacteria. In contrast to their host,
mitochondria are able to use oxidative respiration but not anaerobic respiration. Kroemer suggested
that apoptosis evolved during the domestication of mitochondria and ancestral mitochondria
(protomitochondria) and, in some cases, used to kill host eukaryotic cells. However, for a long
time, it was not clear why apoptotic machinery based on caspases was preserved exclusively in the
unicellular ancestors of animals.
Apoptotic-like cell death is also observed in other non-animal eukaryotic organisms. Such death
is also induced by the release of mitochondrial apoptotic factors. A huge controversy exists as to
whether the cell death of other eukaryotes should be named ‘apoptosis’, since the key animal apoptotic
factor, caspase, seems to be encoded exclusively by animal genomes. In a very recent paper [11], we
performed ancestral state reconstruction of primordial mitochondrial apoptotic machinery used both
by animals and other eukaryotes. This study indicates that apoptosis and apoptosis-like cell death
evolved due to an evolutionary ’arms race’ conducted between ’prey’ protomitochondrion (ancestral
mitochondria) and ’predator’ primitive eukaryotes. Additionally, it turns out that caspases were
actually present in ancestral apoptotic machinery and ‘true’ caspase-based apoptosis appeared during
mitochondrial domestication.
We came to the conclusion that our phylogenetic study suggests an apoptotic explanation of
Warburg and inverse Warburg effects. Here, we present this hypothesis. Namely, we suggest that
Warburg and inverse Warburg effects were already present in the ancestral state of eukaryotes. There
was an antagonistic interaction between anaerobic “glycolytic” predators and aerobic protomitochondrial
prey. Both types of organisms were trying to kill each other and suppress each other’s metabolism.
The multiplication of aerobic organisms was causing predator cell death (apoptosis). These mechanisms
were ‘frozen’ and maintained in extant organisms. As a result, there is a frozen conflict between
“survival” glycolytic metabolism and ‘anaerobic’ apoptotic metabolism.
This hypothesis leads to experimentally testable predictions. The inactivation of apoptotic factors
should cause perturbations in aerobic respiration in different eukaryotic organisms. Actually, in our
recent, aforementioned paper, we showed such experiments using yeast. Yeast apoptotic machinery is
extremely simplified in comparison to animal machinery. However, it turns out that inactivation of
key apoptotic factors causes perturbations in mitochondrial metabolism.
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The hypothesis presented here is also supported by other observations, for example, apoptotic
factors, such as cytochrome c and apoptotic induction factors (AIFs), are directly involved in respiration
and oncogenic mutations have been well described in mitochondrial genes and genes involved
in respiration.
The medical implications of our hypothesis are also discussed in this paper, including implications
for nutrition. We also discuss the testable expectations based on our hypothesis.
2. Aging
Aging is one of the biggest mysteries of biology. In humans, health is most stable beyond the
ages of about 50 years old [3]. In the case of older humans, age has a significant impact on health
and mortality, i.e., the probability of serious illness or death increases rapidly with age. The risks for
developing cardiovascular diseases, diabetes, visual impairment, dementia, and cancer dramatically
increase with age [1–3]. In the majority of cases, age-related diseases are caused by molecular changes
and molecular degeneration. There is an age-related accumulation of mutations in DNA [22,23]
and protein aggregation leading to the formation of toxic protein aggregates [24,25]. Aging causes
disruption in the homeostasis of whole organisms [23]. A portion of the pathological changes associated
with aging are caused by dysregulation of apoptotic programmed cell death and cellular proliferation,
leading to cancer and neurodegenerative diseases. Such dysregulation leads to cancer in tissues in
which programmed cell death is suppressed [26,27]. There are tissues in which mitochondrial apoptotic
machinery is particularly active in young organisms [28]. In contrast, in neuron cells, pathological
activation of apoptotic cell death leads to neurodegenerative diseases, such as Alzheimer’s disease [14]
or Parkinson’s disease [15].
3. Animal Apoptosis—A Form of Programmed Cell Death?
Animal apoptosis is a very particular kind of cell death [29], which was first described by Kerr
in 1972 [4]. It can be easily distinguished from other kinds of cell death using morphological and
biochemical features. At the initial stage of apoptosis, there is a membrane permeability transition,
characterized by the breakdown of the inner mitochondrial transmembrane potential. In the next
stage, chromatin condensation and nuclear fragmentation occur. Then, dying cells are fragmented into
apoptotic bodies with ultrastructurally well-preserved fragments covered by membranes which are
ingested by other cells. The cytoplasmic material of dying cells is isolated from the immune system by
the membranes of apoptotic bodies. So, the production of apoptotic bodies is a mechanism by which
organisms avoid the activation of the immune system and inflammation [29].
In classical studies performed on C. elegans, it was shown that animal apoptosis is a type of
programmed and not accidental cell death. Adult worms have a predetermined number of cells—an
adult hermaphrodite has 959 cells, and an adult male has 1031. During development, a predetermined
number of cells dies (131 in case of the hermaphrodite) [30,31]. Apparently, in this case, cell death
is programmed. It turns out that these cells are apoptotic [32]. It was shown later that apoptosis
plays an important role in the biology of different animal organisms and medicine [29]. As mentioned
previously, dysregulation of apoptosis leads to cancer and neurodegenerative diseases. However,
the mechanisms of such dysregulations are opposite. In the case of cancer, there is a pathological
repression of apoptosis. In the case of neurodegenerative diseases, such as Alzheimer’s disease,
apoptosis is activated.
4. Cancer and Apoptosis
Apoptosis is a key part of the intrinsic tumor suppression mechanisms. During neoplastic
transformation, malignant stresses occur, such as hypoxia, perturbation of microtubule
depolymerization during the mitotic G2/M transition, and genomic instability. Such stresses
induce apoptosis. Different anticancer therapies are based on the induction of apoptosis [27,29,33].
Radiotherapy [34] and cisplatin [35] induce apoptosis by damaging DNA and artificially inducing
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genomic instability. Taxol-based drugs cause microtubule depolymerization during the mitotic G2/M
transition by stabilizing microtubules during mitosis [36–38].
5. Neurodegenerative Diseases and Apoptosis
Proteins tend to aggregate in highly organized, non-functional amyloid structures [36]. Although
amyloid formation is inevitable, it is slow and subject to a kinetic barrier [36]. Apparently, amyloids
are mainly homo-polymers. Different disorders, such as Parkinson’s disease, Alzheimer’s disease,
spongiform encephalopathy, and type II diabetes, are caused by the formation of toxic amyloid fibrils.
In the case of Parkinson’s disease, central roles are played by the formation of α-synuclein amyloid
fibrils [25,39], whereby the aggregation of synuclein leads to disease [40–42]. The critical feature of
Alzheimer’s disease is the deposition of amyloid beta (Aβ) peptide [14,43–45]. Both diseases lead to
pathological apoptosis in neurons [14,15].
6. Inverse Comorbidity of Cancer and Apoptosis
It has been shown that the occurrence of both cancer and Alzheimer’s dementia increases
exponentially with age [1–3,21]. However, different studies have shown that cancer and
neurodegenerative diseases are inverse comorbidities between. It has been shown that there are
low cancer rates among patients with Parkinson’s [17,19,20,46] and Alzheimer’s diseases [17,18,21].
In contrast, people with a cancer or with a history of cancer have a reduced risk of these diseases [17–21].
7. Warburg Hypothesis
Normal, healthy cells use oxidative mitochondrial phosphorylation for respiration. In contrast,
in many cancers, a shift is observed from oxidative mitochondrial respiration towards non-oxidative
respiration. This is a classical Warburg observation [16]. He claims that “Cancer cells originate from
normal body cells in two phases. The first phase is the irreversible injuring of respiration. (...) The
irreversible injuring of respiration is followed, as the second phase of cancer formation, by a long
struggle for existence by the injured cells to maintain their structure, in which a part of the cells perish
from lack of energy, while another part succeed in replacing the irretrievably lost respiration energy by
fermentation energy”.
Later, different oncogenic mutations were described. It turns out that apparently, “mitochondrial
damage” is not the main factor leading to cancer disease. It was shown that the overexpression of
glycolytic genes, which is a hallmark of the Warburg effect, is observed in about 71% of cancers [47].
Partly, this observation could be explained by hypoxic conditions in the tumor environment. It has
been shown that prolonged hypoxia causes a shift towards mitochondrial respiration [48]. However,
as already mentioned in the classical papers of Warburg, usually cancer cells use mainly non-oxidative
forms of respiration, even in the presence of sufficient oxygen, to support mitochondrial oxidative
phosphorylation [16,49]. Different studies have indicated that Warburg effect is beneficial for cancer
cells. For example, it has been shown that in human tumor cells, the Warburg effect can be reversed
by replacing the embryonal isoform of pyruvate kinase expressed in cancers with its adult isoform.
Such modified cancer cells have increased oxygen consumption. This reversion of the Warburg effect
correlates with a reduced ability to form tumors in nude mouse xenografts [50]. Faubert and colleagues
showed that the inactivation of gene AMPK (5′AMP-activated protein kinase) induces a shift towards
anaerobic respiration and causes more rapid development of cancers in transgenic mice which have
a predisposition for cancer formation [51]. A very recent physics paper indicates that it is likely that
cancer “glycolytic” cells have higher temperature than other cells [52].
However, the Warburg effect is not an obligatory change leading to neoplastic transformation,
as there are cancers in which the Warburg effect is not observed or is even reversed, i.e., cancer cells
use mainly mitochondrial respiration [53].
Assuming that the Warburg effect plays a role in neoplastic transformation, it may (i) stimulate
proliferation or (ii) stimulate cell death in tumor cells. The Warburg effect has a pleiotropic impact on
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cancer and supports its development by many different mechanisms. As a result, it is very hard to judge
which of them play crucial roles. However, the majority of scholars believe that the most important factor
is the first explanation. For example, in very recent seminal reviews, the second explanation was barely
mentioned or not mentioned at all [54,55]. There are many mechanisms involved in the stimulation of
cancer cell proliferation by the Warburg effect [54]. The Warburg effect is unexpected and puzzling,
as oxidative phosphorylation is much more efficient (e.g., generates more ATP) than fermentation.
Anaerobic respiration is more efficient than aerobic metabolism at incorporating nutrients into biomass.
In their paper, Thomson and coworkers pointed out that “For most mammalian cells in culture, the only
two molecules catabolized in appreciable quantities are glucose and glutamine.” [49]. Therefore, it is
beneficial for cells to use glucose as a source of carbon instead of using it to produce ATP and CO2
during mitochondrial respiration. Lloyd Demetrius developed a mathematical model which indicates
that the Warburg effect is more efficient at incorporating nutrients into biomass [56]. Another possible
mechanism involved in the stimulation of cancer cell proliferation by the Warburg effect emerged
from a recent study which showed that the synthesis of ATP is much more rapid due to anaerobic
respiration [57]. In detail, it turns out that the production of lactate from glucose occurs 10–100 times
faster than the complete oxidation of glucose in the mitochondria.
Other scholars point out that the Warburg effect could have a beneficial effect on the impact of
cancer cells on the tumor microenvironment. It causes acidification due to elevated lactate synthesis
during anaerobic respiration [54,58]. It has been shown that acidity causes increased invasiveness of
cancer [58] and that lactate is a hormone that has beneficial activity for cancer. Lactate is involved
in angiogenesis, immune escape, cell migration, and metastasis [59]. A recent experimental study
provided indications that the Warburg effect suppresses the antitumor activity of immune T cells in
tumor microenvironments. According to the suggested model, glucose is required for the proper
anticancer activity of these cells [60]. Due to the Warburg effect, there is elevated glucose consumption
by cancer cells and a decreased glucose level in the tumor microenvironment. A decreased glucose
level inactivates the proper antitumor activity of T cells.
The second explanation is less popular, although has been considered by some scholars. However,
different mechanisms of apoptosis suppression in ‘glycolytic’ cells have been described.
It has been shown many times that the inactivation of apoptosis in cancerous cells induces the
Warburg effect. Tumor suppressing genes are often directly involved in the regulation of apoptosis
and metabolism (see, as a review, Ref. [61]). Tumor-associated mutations or perturbations suppress
the activity of apoptotic factors such as P53 [62] and PTEN [63–65]. Inactivation of these factors
causes the Warburg effect [65–67]. Neoplastic transformation leads to pathological activation of
oncogenic anti-apototic genes such as HIF [68,69], BCL-2 [70,71], and survivine [37]. These factors
induce glycolysis [72–75].
Indeed, it has been shown many times that the Warburg effect suppresses apoptosis in cancerous
cells. Glycolysis inactivates the apoptotic activity of cytochrome c [76]. The pro-apoptotic activity of
cytochrome c is influenced by its redox state. Glycolysis leads to higher levels of glutathione, which
reduces and inactivates the apoptotic activity of cytochrome c. Cancer cells have high mitochondrial
membrane potential (DeltaPsim) and low expression of the K+ channel Kv1.5, contributing to both
apoptosis resistance and the Warburg effect [77].
It was shown that the anticancer drug candidates dichloroacetate [77], metformin [78,79],
SR9243 [80] and therapeutical RNAi [81] shift metabolism from glycolysis to glucose oxidation and
induce apoptosis. Fasting during anticancer therapy has a similar effect [82].
In conclusion, the Warburg effect has a pleiotropic impact on cancer cells, inducing both their
multiplication and the suppression of apoptosis.
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8. The Inverse Warburg Hypothesis
In contrast to the immortal cancer cells, neuron cells are terminally differentiated. Such
cells also predominantly use aerobic mitochondrial respiration. As described above, cancer and
neurodegenerative diseases are inverse comorbidities [17–21].
These observations led to the formulation of the ‘Inverse Warburg hypothesis’. According to
this hypothesis, active mitochondrial metabolism accelerates cellular aging. In agreement with the
suggested model, regulation of mitochondrial respiration would compensate for the mitochondrial
dysfunction that occurs during pathological aging [83,84]. In accordance with this model, it has been
shown that an early marker of neuron susceptibility to Alzheimer’s disease is an increase in mtDNA
and in levels of the cytochrome oxidase protein [85].
A recent paper showed that mitochondrial metabolism is regulated in opposing ways in
Alzheimer’s disease and lung cancer [86]. The authors performed a bioinformatics analysis of modern
transcriptomic data to check which genes are activated or repressed in both diseases and observed that
genes involved in mitochondrial metabolism are regulated oppositely. This observation supports the
hypothesis that mitochondrial metabolism is involved in the inverse comorbidity between these diseases.
9. Mitochondria Are Key Players in Oxidative Respiration and Apoptosis
As shown in previous chapters, pathological suppression of apoptosis occurs in cancer tissue in
which aerobic respiration tends to be lower. In contrast, pathological activation of apoptosis during
neurodegenerative diseases occurs in neurons, where oxidative respiration is particularly active.
One can ask whether there is any connection between oxidative respiration and apoptosis.
Previous studies have indicated that such connection actually exists. There is one key player common
for apoptosis and oxidative respiration. This common connection is mitochondria.
Aerobic respiration takes place in the mitochondria. Indeed, mitochondria are key players in
animal apoptosis and are involved in different apoptotic initiation pathways. For example, apoptosis
is initiated by mitochondrial permeability transition, regulated by BCL-2 type proteins [70,87–89].
It induces the release of cytochrome c [90]. Cytochrome c is part of the oxidative chain and is also
an apoptotic factor [85]. Released cytochrome c induces the proteolytic activity of caspase, which is
the main animal apoptotic protease [7]. The mechanism of this activation has been well described.
Cytochrome c is also part of a multiprotein apoptosis-activating complex called the apoptosome [7].
There are many other mitochondrial apoptotic factors, such as EndoG nuclease, OMI/HTRA proteases,
apoptotic induction factors, and some caspases [29].
10. The Endosymbiotic Theory of Origin of Apoptosis and Oxidative Respiration
The hypothesis of the mitochondrial origin of apoptosis was first postulated by Margulis [91].
According to this theory, mitochondria evolved from bacterial ancestors (protomitochondrions) due to
endosymbiosis. Mitochondria possess the machinery required for aerobic respiration. Acquiring this
machinery was beneficial for the ancient eukaryotes (named protoeukaryotes). Because mitochondria
are also main organelles involved in apoptosis, the mitochondrial theory of apoptotic origin was
formulated firstly by Kroemer [92]. According to his theory, extant apoptotic factors are modified
bacterial toxins used by protomitochondrions against their host. This theory was later tested using
phylogenetic studies by Koonin and Aravind [93,94]. These studies showed that apoptotic factors
actually have a bacterial origin. However, early phylogenetic studies did not explain key details. It was
not clear, for example, why apoptotic machinery based on caspases was preserved exclusively in
multicellular animals, but not in other eukaryotes, such as plants or fungi. In addition, the function of
apoptosis based on caspases in unicellular ancestors of animals was unclear.
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11. Apoptotic-Like Cell Death (Apoptosis?) of Non-Animal Organisms
Although genomes of non-animal organisms do not encode the key animal apoptotic factor,
caspase, apoptotic-like cell death has been described in many such organisms. Whether such cell
death should be named apoptosis is a controversial topic. Recently, yeast biologists decided that
since it is so similar to classical apoptosis, it make no sense to use different terms [95]. Non-animal
apoptosis has many cytological and biochemical hallmarks of classical animal apoptosis. It is also
initiated by the release of mitochondrial “apoptotic” factors. During cell death, self-destruction of
DNA is also observed. Such organisms do not use caspases, which are the main animal apoptotic
proteases. However, caspase is replaced by another remotely related protease, called metacaspase.
Indeed, many orthologs of several animal apoptotic factors play critical roles in apoptotic-like cell
death in non-animal organisms (for example, apoptotic induction factors (AIFs), nuclease EndoG, or
cytochrome c) [11,29,96].
The function of apoptotic like-cell death of unicellular organisms is very controversial. Some scholars
claim that this type of cell death is not regulated and rather, is accidental [97]. However, there are many
described examples in which apoptosis is described as a form of altruistic cell suicide [29,98–100].
12. Ancestral State Reconstruction of Apoptosis Machinery
Recently, we questioned whether animal apoptosis and apoptosis-like cell death of other
eukaryotes have a common origin [11]. To answer this question, we performed ancestral state
reconstruction. Using parsimony assumption, we checked which elements of apoptotic machinery
were present in an ancestral state in the first eukaryotes. It turns out that this machinery was rather
complex. According to our reconstruction, the ancestral eubacterial apoptotic machinery contained
both caspases and metacaspases, four types of AIFs, both fungal and animal OMI/HTRA proteases,
and various apoptotic DNases. Different ancient factors were lost in different clades. For example,
the aforementioned caspases were lost in the majority of non-animal eukaryotes. However, it is
worth mentioning that through the use of phylogenetic searches, we discovered that caspases are also
encoded by the recently sequenced unicellular organism Reticulomyxa. Our reconstruction suggests
that apoptosis evolved due to a putative evolutionary arms race between primitive eukaryotes, which
were predators, and protomitochondrions, which were prey. Prey produced as many toxins as possible.
These toxins were transformed into extant apoptotic factors during evolution. Different toxins were
lost in different systematic groups. As a result, different organisms use different toxins/apoptotic
factors. For example, animals use caspases, but other eukaryotic organisms use metacaspases.
13. An Apoptotic Explanation of the Warburg and the Inverse Warburg Hypotheses
Here, we present the hypothesis that the impact of cellular metabolism on apoptosis described
by Warburg and inverse Warburg hypotheses already existed in the ancestral state (see Figure 1).
In this state, the activity of the aerobic respiration and apoptotic systems was linearly proportional
to the number of living protomitochondrions. Protomitochondrions multiplied under conditions
supporting oxidative respiration and killed protoeukaryotes. This phenomenon was a primitive
form of the Warburg phenomenon.In contrast, under conditions supporting glycolytic respiration,
primitive eukaryotes multiplied rapidly and killed protomitochondrions. This was the primitive
inverse Warburg phenomenon.
This ancient mechanism was somehow maintained over evolutionary processes and is present in
current human cells.
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14. The Warburg and the Inverse Warburg Hypotheses in Yeast
Assuming that principles described by the Warburg and the inverse Warburg hypotheses have an
endosymbiotic origin, such principles should also be observed in non-animal eukaryotes. Actually,
recent studies suggest that the War urg [11] and inverse Warburg hypotheses are observed in
yeast [101].
We showed that cancer-like inactivation of apoptotic factors in yeast also causes perturbations in
aerobic respiration [ 1]. We investigated the well-described apoptotic factors NDI1, a mitochondrial
apoptotic induction factor (AIF); NUC1, a mitochondrial apoptotic DNase ENDOG; MCA1,
a cytoplasmic metac spase; and NMA111, a cytoplasmic apoptotic protease, using yeast Saccharomyces
cerevisiae W303. Deleti n of these factors causes cancer-like suppression of t tic activity. It turns
out that such deletions are beneficial under anaerobic conditions. During c -cultivation experiments
performed under anaerobic conditions, wild-type ell gradually lost competition with mutants.
In contrast, under aerobic conditions, all of the studied m tants lost competitions with wild-type
cells. To verify how the studied del tions affect th a ility to perform mitochondrial respiration, we
exa ined the growth of the mutants and wild-type cells on a medium containing glyc rol as a source
of carbon. The growth of east in this m dium require mitochondrial respiration. It turns out that
‘apoptotic’ mutants were not able to grow on this medium.
In conclusion, the results presented above indicat that in yeast, cancer-like inactivation of
apoptotic machin ry leads to remodeling of met b lism and a shift towards anaerobic respiration.
Recent studies also indicate that, in yeast, as postulated by the ‘inverse Warburg hypothesis’,
the activation of apoptotic activity occurs in cells which use mitochondrial respiration. Indeed, s me
important details describing this process have been revealed. It was shown that the activation of
mitochondrial respir ti n contributes to th activati n of RAS-dependent apoptosis. RAS protein
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accumulates mainly at the plasma membrane and in the nucleus during growth on medium containing
glucose [101,102]. In contrast, it localizes mainly in the mitochondria in wild-type glucose-starved cells.
However, it moves from the mitochondria to the nucleus after the addition of glucose to the medium.
Also, the deletion of hexokinases—key enzymes of anaerobic respiration—causes mitochondrial
localization of RAS small GTPase. Additionally, it has been shown that the activation of apoptosis by
acetic acid causes translocation of RAS from the plasma membrane to the mitochondria. Furthermore,
it was shown that the activation of apoptosis induced by acetic acid and H2O2 is stronger in the
above mentioned deletion mutants with inactivated hexokinases [101,102]. It also turns out that
RAS-dependent apoptosis is metacaspase-independent and that AIF1 is involved in the apoptotic
pathway induced by RAS [102].
The apoptotic explanation of the inverse Warburg hypothesis presented here also predicts that
the mechanism of apoptosis activation by neurotoxic aggregates is evolutionary conserved and cells
could be rescued by inactivation of mitochondrial metabolism.
Actually, recent studies with yeast models confirmed this expectation in the case of Parkinson’s
disease. As already mentioned, Parkinson’s disease is caused by the aggregation of α-synuclein [42].
Heterologous expression of this protein in yeast is toxic for aging cells [103]. It turns out that apoptosis
induced by toxic aggregates requires endonuclease G (ENDOG). Similar observations were made in
C. elegans and flies. In C. elegans, heterologous expression of human α-synuclein is neurotoxic, but
deletion of EndoG protects these cells. In flies, heterologous expression of human α-synuclein is also
neurotoxic, and depletion of EndoG by RNA interference protects neuron cells as well [40]. It was
also shown that in yeast, functional mitochondria are required for synuclein toxicity. The abrogation
of mitochondrial DNA (rho0 type mutation) protects cells against the toxic activity of α-synuclein
aggregates [103].
In the case of Alzheimer’s disease, the situation is less obvious. During the progression of the
disease, toxicity is caused by the aggregation of amyloid beta peptide. In humans, toxic forms of this
peptide are generated by proteolytic cleavage of APP, the transmembrane amyloid precursor protein,
during processing in the secretory pathway. The expression of amyloid human beta peptide is toxic for
yeast when it is directed to secretion by fusion to an ER targeting signal to the N-terminus. It has been
shown that such toxic peptides have an impact on mitochondria metabolism [104]. A very recent study
showed that toxicity caused by human amyloid beta peptide affects mitochondria. Such mitochondria
have structures typical of aged yeast (they are more fragmented). Indeed, there is an increase in the
production of reactive oxygen species (ROS) in cells accumulating amyloid beta. It is important to note
that the production of ROS is a typical hallmark of apoptosis [105].
In conclusion, the apoptotic mechanisms involved in Warburg and inverse Warburg are very old.
In both yeast and animals, the inactivation of apoptosis leads to the repression of aerobic mitochondrial
respiration. In contrast, the activation of mitochondrial metabolism plays a role in the activation of
apoptosis. Indeed, the expression of human neurotoxic proteins has an identical impact in both types
of organisms and activates the EndoG-dependent apoptotic pathway.A comparison of the apoptotic
traits of animals (humans) and yeast are shown in Table 1.
Table 1. Human and yeast apoptosis mechanisms. The table indicates that the majority of these apoptotic
traits appeared before human/fungi diversification (probably even before the origin of eukaryotes).
Mechanism of Apoptosis S. cerevisiae Homo Sapiens
Caspase − +
Metacaspase + −
Cytochrome c induced apoptosis + +
Mitochondrial permeability transition + +
EndoG + +
Parkinson-like activation of EndoG apoptotic pathway by α-synuclein aggregates + +
AIFs (Apoptotic Induction Factors) + +
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Table 1. Cont.
Mechanism of Apoptosis S. cerevisiae Homo Sapiens
OMI/HTRA apoptotic protease + +
Suppression of apoptotic activity causes co-suppression of aerobic respiration
(Warburg effect) + +
Aerobic respiration stimulates apoptotic activity (inverse Warburg effect) + +
15. Medical Implications of Our Observations
The hypotheses presented here have important medical implications. As already mentioned,
epidemiological studies suggest that general aging is a main risk factor in the development of cancer
and neurodegenerative diseases. Recent studies indicate that a general mechanism of aging exists
and that this process is regulated to some extent. On the molecular level, there are at least three
different biochemical pathways that control aging: insulin/insulin-like growth factor 1 (IGF-1),
tuberous sclerosis complex (TSC), mammalian target of rapamycin (mTOR), and the sirtuins [106].
Caloric restriction, exercise, and proper diet have beneficial impacts on aging and the development of
cancer and Alzheimer’s disease (AD). Experiments with animals have shown that caloric restriction
reduces the risk of cancer and neurodegeneration [107]. It has been shown that adherence to a
Mediterranean-type diet is associated with a reduced risk of AD [108]. Similar observations were
made in the case of cancer [109,110]. Physical activity also reduces the risk of developing these
diseases [111,112].
However, there is an inverse comorbidity between these diseases. Our hypothesis suggests
that anticancer treatment may accelerate neuronal aging, and vice versa, factors inhibiting neuronal
aging may stimulate neoplastic transformation. It has been shown that estrogen replacement therapy
increases the probability of developing cancer [113,114] and decreases the probability of developing
dementia [115]. We expect that there will be more similar cases discovered in the future.
16. Conclusions
In this paper, we presented an apoptotic and endosymbiotic explanation of the Warburg
and the inverse Warburg hypotheses. Namely, the bacterial ancestors of extant mitochondria—
protomitochondrions—produced toxins and performed oxidative respiration. The production of
toxins and activity of oxidative respiration was approximately proportional to the number of
protomitochondrions. This ancestral correlation between the activity of mitochondrial metabolism and
apoptotic activity was maintained in yeast and animals.
The aforementioned hypothesis led to the following testable predictions:
- The induction of apoptosis causes a metabolic shift towards aerobic respiration;
- The stimulation of aerobic respiration induces apoptosis;
- The suppression of apoptosis causes a metabolic shift towards anaerobic respiration;
- The suppression of aerobic respiration inhibits apoptosis.
As described above, these predictions have been confirmed by many experimental studies
including our very recent paper. Indeed, it is expected that the ancestral correlation between activity
of mitochondrial metabolism and apoptotic activity described here is maintained throughout the
eukaryotic world. If this is the case, this correlation would be observed also in plants, green algae, and
unicellular protozoa, in which apoptosis/apoptosis-like cell death has been well described [29,96].
In conclusion, evolutionary apoptotic history has a strong impact on extant eukaryotic organisms.
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